A study recently published in the New England Journal of Medicine shows a highly increased risk to develop breast cancer for carriers of pathogenic mutations in PALB2 gene. Antoniou et al. determined a ninefold increase in breast cancer risk for both genders.
CeGaT offers the analysis of PALB2 and other risk genes via its panel for breast and ovarian cancer (CAN02).
You can find more information about the study on the website of the New England Journal of Medicine.